OR WAIT 15 SECS
Clinical site visits by patients may not be possible as healthcare providers focus their efforts on patients who require urgent care as a result of the COVID-19 pandemic. ERT has announced a cardiac safety solution that helps biopharmaceutical researchers continue important clinical trials during current global ‘stay home’ mandates. The solution enables clinician-administered ECG readings, using ERT’s provisioned, FDA-cleared devices or other investigative site-owned equipment.
To learn more, click here.